Results 141 to 150 of about 43,829 (215)

A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland [PDF]

, 2019
Bielecki, Braczkowska, Braczkowska, Brydak, Corcoran, Czarkowski, D.R. Gorman, Donaldson, Dubé, European Centre for Disease Prevention and Control, Forster, Fournet, Ganczak, Ganczak, Ganczak, Gorman, Jaroszewicz, Jaroszewska, Jayaweera, Jorgensen, K. Bielecki, K.G. Pollock, Kanitz, Korczynska, L.J. Willocks, Larson, Larson, Larson, Larson, Larson, McCann, Mixer, Mrozek-Budzyn, Mrozek-Budzyn, Mrozek-Budzyn, Napolitano, Owsianka, Pollock, Sawada, Sim, Sime, Zarobkiewicz, Żuk   +42 more
core   +1 more source

Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins. [PDF]

J Infect Dis
Chen MH, Perelygina L, Hao L, Beard RS, Lackner C, Farcet MR, Karbiener M, Icenogle J, Kreil TR.   +8 more
europepmc   +1 more source

Intralesional Measles, Mumps and Rubella Vaccine versus Formic Acid Puncture in the Treatment of Common Warts: A Prospective Randomised Study.

Indian J Dermatol, 2023
D'Souza MJ, Hundi GK, Dandekeri S, Jayaraman J.   +3 more
europepmc   +1 more source

A Comparative Analysis of Efficacy of Intralesional Mumps-Measles-Rubella Vaccine Versus 5-Fluorouracil in the Treatment of Palmoplantar Warts. [PDF]

Indian Dermatol Online J, 2022
Sunny AS, Doshi BR.
europepmc   +1 more source

The Oncogenic Human Papillomavirus Involvement as a Risk Factor of Measles, Mumps, and Rubella Vaccine Immunotherapy Failure in Anogenital Warts. [PDF]

Int Med Case Rep J
Achdiat PA, Ismiranty D, Hindritiani R, Rizqandaru T, Usman HA, Maharani RH.   +5 more
europepmc   +1 more source

Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing. [PDF]

Vaccine X, 2021
Gillis JH, Thomas KN, Manoharan S, Panchakshari M, Taylor AW, Miller DF, Byrne-Nash RT, Riley C, Rowlen KL, Dawson E.   +9 more
europepmc   +1 more source

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]

PLoS One
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.   +11 more
europepmc   +1 more source

Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial.

BMJ, 2023
Zimakoff AC, Jensen A, Vittrup DM, Herlufsen EH, Sørensen JK, Malon M, Svensson J, Stensballe LG.   +7 more
europepmc   +1 more source

The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine. [PDF]

J Infect Dis, 2022
Quach HQ, Chen J, Monroe JM, Ratishvili T, Warner ND, Grill DE, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB.   +9 more
europepmc   +1 more source

Freeze-drying of live virus vaccines : a review [PDF]

, 2015
Daoussi, R, De Beer, Thomas, Hansen, Laurent, Remon, Jean Paul, Vervaet, Chris   +4 more
core   +2 more sources